What Adivo Associates does

Adivo Associates is a life sciences commercialization consultancy that delivers integrated advisory services across the biopharmaceutical product lifecycle, spanning commercial strategy, market access, health economics, and medical affairs. The firm serves biopharmaceutical, biotech, and life sciences organizations, supporting them through increasing regulatory complexity, value demonstration requirements, and global product launches. Adivo Associates operated as one of five specialist consultancies—alongside Herspiegel, Decisive Consulting, Fiecon, and Sixsense Strategy Group—that merged in April 2026 to form Acumetis, a unified global commercialization platform backed by private equity firm DFW Capital. The combined entity now deploys over 350 experts across 15+ countries and 50+ geographic markets, serving more than 150 life sciences organizations with a track record of supporting over 200 product launches across two decades.

Adivo Associates (now operating as "Acumetis | Adivo") functions as a B22B professional services firm using enterprise field sales motion. Revenue is generated through project-based and retainer consulting engagements with senior consultants and partners directly engaging biopharma leadership. The firm's offices span the United States (headquarters listed variously in San Francisco per firmographic data and Yardley, Pennsylvania per merger filings), Canada (Toronto), the United Kingdom (London), and India. The firm's underlying "technology" is its accumulated domain expertise, consulting methodology, and content library from hundreds of product engagements rather than proprietary software or AI systems; no patents, proprietary models, or technology platforms are disclosed. The company has no app, API, or SDK offerings.

The firm's go-to-market relies on direct enterprise engagement, industry conferences, and professional networks within the biopharmaceutical sector. Marketing is targeted at senior decision-makers at life sciences companies, with services sold as integrated lifecycle engagements rather than discrete point solutions. Pricing is not publicly disclosed but follows the standard professional services model of project quotes and retainers.

Name

Adivo Associates

Legal name

Adivo Associates

Website

https://adivoassociates.com

Company type

Private

Founded year

2026

Operating status

Operating

Headcount range

101–250 employees

Short description

Adivo Associates provides life sciences commercialization advisory—covering commercial strategy, market access, health economics, and medical affairs—to biopharma and biotech clients. Since April 2026 it operates under the unified Acumetis brand, deploying 350+ experts across 15+ countries serving 150+ organizations.

Ownership category

akta.pro rank

Product category

Life Sciences Consulting

NAICS

Management Consulting Services (54161), Marketing Consulting Services (541613), Professional, Scientific, and Technical Services (54)

SIC

Services-Management Consulting Services (8742), Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Strategic Partnerships, Alliances & JVs Advisory (BPAHADAI)

Keywords

• Life sciences consulting
• Biopharma advisory
• Market access services
• Health economics consulting
• Medical affairs advisory

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Consulting and Advisory Services: Professional services revenue model providing integrated expertise across commercial strategy, market access, health economics, and medical affairs to life sciences organizations. Services are delivered through expert consultants across the product lifecycle.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Adivo Associates is a global strategy and marketing consultancy providing integrated advisory services to life sciences organizations across the entire biopharma product lifecycle. Offerings span commercial strategy, market access, health economics, and medical affairs, delivered by 350+ expert consultants under the unified Acumetis brand following a 2026 merger of five specialist consultancies.

Product overview

Adivo Associates has merged with four other life sciences consultancies (Herspiegel, Decisive Consulting, Fiecon, and Sixsense Strategy Group) to form Acumetis, a single integrated brand. Acumetis functions as a unified commercialization platform offering complementary services across the biopharma asset lifecycle—commercial strategy, market access, health economics, and medical affairs—with over 350 experts serving more than 150 life sciences organizations globally.

Differentiator

Problem solved

Functional benefit

Products and services

• Commercial Strategy Advisory Advisory services providing commercial strategy expertise to biopharmaceutical and life sciences organizations across the product lifecycle, supporting product commercialization decisions and launch planning for enterprise life sciences clients.
• Market Access Services Advisory services supporting life sciences organizations in navigating global market access, including payer engagement, access strategy, and reimbursement support across multiple geographic markets for biopharma clients.
• Health Economics Consulting Health economics advisory services helping biopharmaceutical clients demonstrate product value through economic modeling, evidence generation, and value communication strategies for payers and stakeholders.
• Medical Affairs Advisory Medical affairs advisory services providing scientific and clinical expertise to support biopharmaceutical product positioning, stakeholder engagement, and evidence dissemination throughout the product lifecycle for life sciences clients.

Quantifiable outcome

• 200+ product launches supported by founding firms over two decades
• +2 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• BrandingBusinessmajorGTM or Marketing Partner · 2 June 2026BrandingBusiness, a B2B brand strategy firm, led the brand development for Acumetis including name derivation from Greek words, corporate messaging framework, logo, and visual identity system with the tagline 'Reframe what's possible.' This was a strategic branding engagement to create and launch the new global brand.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• ZS Associates: ZS Associates is a global consulting firm specializing in pharmaceuticals and life sciences, with deep expertise in sales, marketing, and commercialization strategy that directly overlaps with Adivo's service lines.
• Herspiegel Consulting: Herspiegel is one of the five legacy firms that merged into Acumetis alongside Adivo; it operates as a life sciences commercialization consultancy focused on launch and field force strategy, making it a directly comparable peer.
• ClearView Healthcare Partners: ClearView Healthcare Partners is a life sciences strategy consulting firm offering commercial strategy, new product planning, and pricing/market access services, closely aligned with Adivo's commercialization advisory offering.
• Beghou Consulting: Beghou Consulting is a life sciences commercialization and analytics consultancy serving biopharma clients across commercial strategy, market access, and sales/marketing operations — directly comparable to Adivo's core service mix.
• Putnam Associates: Putnam Associates is a strategy consulting firm focused exclusively on life sciences, providing commercial strategy, market access, and pricing/reimbursement advisory — directly overlapping with Adivo's consulting portfolio for biopharma clients.
• Trinity Life Sciences: Trinity Life Sciences is a privately held life sciences commercial strategy and insights consultancy with comparable service offerings across market access, HEOR, and commercial strategy, making it the closest direct peer to Acumetis/Adivo in scale and specialty.

Broad incumbents

• IQVIA: IQVIA is a global life sciences technology and services incumbent offering commercialization, market access, HEOR, and analytics as part of a broader R&D and real-world data platform, competing with Adivo in many of the same biopharma engagements.
• McKinsey & Company (Pharmaceuticals & Medical Products): McKinsey's Pharmaceuticals & Medical Products practice provides commercial strategy, market access, and launch advisory to global biopharma, often bundled with broader transformation work and competing with Adivo for senior-level mandates.
• Boston Consulting Group (Healthcare): BCG's Healthcare practice delivers commercial strategy, pricing, and market access advisory to biopharma clients globally, representing a broad incumbent competitor to Adivo's specialist offering.
• Syneos Health Consulting: Syneos Health provides commercial strategy and launch consulting alongside its CRO operations, offering biopharma clients integrated commercialization services that compete with Adivo's lifecycle advisory work.

Market position

Strengths2 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/AdivoAssociates

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Adivo Associates